Introduction：Basic information about CAS 159445-64-4|Odulimomab, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Odulimomab |
|---|
| CAS Number | 159445-64-4 | Molecular Weight | / |
|---|
| Density | / | Boiling Point | / |
|---|
| Molecular Formula | / | Melting Point | / |
|---|
| MSDS | / | Flash Point | / |
|---|
Names
Odulimomab BiologicalActivity
| Description | Odulimomab (anti-LFA1) is an anti-LFA-1 monoclonal antibody. Odulimomab inhibits proliferation of T lymphocyte and shows protective effects against ischemia and reperfusion injury. Odulimomab can be used for the research of transplant rejection and immunological disease[1][2]. |
|---|
| Related Catalog | Research Areas >>Inflammation/ImmunologySignaling Pathways >>Cytoskeleton >>Integrin |
|---|
| In Vitro | Odulimomab 在体外抑制 T 淋巴细胞增殖，以及 T 和自然杀伤细胞 (NK) 的细胞毒性和抗体产生[2]。 |
|---|
| In Vivo | Odulimomab (1.5 和 0.75 mg/kg；腹腔注射，第 1 次治疗 1.5 mg/kg，然后每天注射 0.75 mg/kg) 对缺血和再灌注损伤有保护作用，对移植后肾功能有所修复[1]。 Animal Model: Cynomolgus Monkeys with renal damage ischemia and kidney autotransplantation[1] Dosage: 1.5 and 0.75 mg/kg Administration: Intraperitoneal injection; 1.5 mg/kg for the first dose and after pedicle clamping followed by daily injection of 0.75 mg/kg until sacrifice Result: Decreased the creatinine level after ischemia and autotransplantation for 3 days and increased the potassium fraction reabsorption. |
|---|
| References | [1]. Martin X, et al. Protective effect of an anti-LFA 1 monoclonal antibody (odulimomab) on renal damage due to ischemia and kidney autotransplantation. Transplant Proc. 2000 Mar;32(2):481. [2]. M. Hourmant & J. P. Soulillou. Interest in an anti-LFA-1 monoclonal antibody in the prevention of reperfusion injury in kidney transplantation. Organ Allocation pp 215–223. |
|---|
Chemical & Physical Properties
| No Any Chemical & Physical Properties |
